MC
AMED

Maverick Capital’s Amedisys AMED Stock Holding History

Maverick Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,449
Closed -$2.29M – 568
2020
Q1 		$2.29M Buy
+12,449
New +$2.21M 0.05% 166
2019
Q4 		– Sell
-36,715
Closed -$4.81M – 344
2019
Q3 		$4.81M Buy
36,715
+36,267
+8,095% +$4.72M 0.07% 156
2019
Q2 		$54K Buy
+448
New +$53.2K ﹤0.01% 279
2019
Q1 		– Sell
-20,740
Closed -$2.43M – 277
2018
Q4 		$2.43M Buy
+20,740
New +$2.44M 0.04% 234

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Maverick Capital's AMED Position: Q2 2020 in Review

Maverick Capital sold out of Amedisys (AMED) in Q2 2020, closing a stake of 12,449 shares — an estimated $2.29M sold.

Maverick Capital first reported a position in AMED in Q4 2018 and held it in 4 quarters. The position peaked at $4.81M in Q3 2019. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

  • Maverick Capital reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
  • Maverick Capital sold 12,449 Amedisys shares in Q2 2020, an estimated $2.29M.
  • Maverick Capital first reported a position in Amedisys in Q4 2018 and held it in 4 quarters.
  • Maverick Capital's Amedisys position peaked at $4.81M in Q3 2019.
  • 354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Maverick Capital's 13F filing for Q2 2020, filed 14 Aug 2020.